Irena Royzman and Steven Zalesin to Present Webinar on “Five Years of BioPharma IPRs: Where We Are and What Now”
Partners Irena Royzman and Steven Zalesin will co-present a webinar for Bloomberg BNA entitled, "Five Years of BioPharma IPRs: Where We Are and What Now".
It has been five years since the first inter partes review proceedings (IPRs) were filed, transforming patent litigation in the United States. This program will cover what in-house counsel need to know about IPRs for US biotech and pharmaceutical patents. Ms. Royzman and Mr. Zalesin will discuss the lessons learned over the last five years, the latest trends for bio/pharma patents, parallel litigation under the Hatch-Waxman Act and legislation for biosimilars (BPCIA), and key strategies to protect these important patents. They will also provide an analysis of what is working and what is not before the PTAB and on appeal to the CAFC, and strategies for leveraging district court proceedings in IPRs.
To learn more, or to register, click here.